186 related articles for article (PubMed ID: 16213619)
21. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue.
van de Pol M; Levendag PC; de Bree RR; Franssen JH; Smeele LE; Nijdam WM; Jansen PP; Meeuwis CA; Leemans CR
Brachytherapy; 2004; 3(2):78-86. PubMed ID: 15374539
[TBL] [Abstract][Full Text] [Related]
22. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
23. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
25. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies.
Tran PT; Su Z; Hara W; Husain A; Teng N; Kapp DS
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):504-11. PubMed ID: 17560736
[TBL] [Abstract][Full Text] [Related]
26. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results.
Ishikawa H; Nonaka T; Sakurai H; Tamaki Y; Kitamoto Y; Ebara T; Shioya M; Noda SE; Shirai K; Suzuki Y; Takahashi T; Nakano T
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):452-9. PubMed ID: 19419819
[TBL] [Abstract][Full Text] [Related]
28. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
[TBL] [Abstract][Full Text] [Related]
29. Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma.
Ordeanu C; Coza O; Gavris S; Todor N; Szilagy E; Bako M; Cernea V; Ghilezan N; Nagy V
J BUON; 2007; 12(2):221-6. PubMed ID: 17600876
[TBL] [Abstract][Full Text] [Related]
30. Patterns of failure and outcome in patients with carcinoma of the anal margin.
Khanfir K; Ozsahin M; Bieri S; Cavuto C; Mirimanoff RO; Zouhair A
Ann Surg Oncol; 2008 Apr; 15(4):1092-8. PubMed ID: 18231838
[TBL] [Abstract][Full Text] [Related]
31. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
32. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis.
Mantz CA; Dosoretz DE; Rubenstein JH; Blitzer PH; Katin MJ; Garton GR; Nakfoor BM; Siegel AD; Tolep KA; Hannan SE; Dosani R; Feroz A; Maas C; Bhat S; Panjikaran G; Lalla S; Belani K; Ross RH
Brachytherapy; 2004; 3(4):183-90. PubMed ID: 15607149
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J
Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519
[TBL] [Abstract][Full Text] [Related]
34. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
[TBL] [Abstract][Full Text] [Related]
35. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
[TBL] [Abstract][Full Text] [Related]
36. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
37. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
[TBL] [Abstract][Full Text] [Related]
38. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up.
Pötter R; Dimopoulos J; Bachtiary B; Sissolak G; Klos B; Rheinthaller A; Kirisits C; Knocke-Abulesz TH
Radiother Oncol; 2006 Apr; 79(1):80-6. PubMed ID: 16516316
[TBL] [Abstract][Full Text] [Related]
39. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
[TBL] [Abstract][Full Text] [Related]
40. Interstitial brachytherapy for soft tissue sarcoma: A single institution experience.
Mierzwa ML; McCluskey CM; Barrett WL; Lowy A; Sussman J; Sorger J
Brachytherapy; 2007; 6(4):298-303. PubMed ID: 17959424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
